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DRUG-RELATED MORTALITY IN MAINE
Patterns of
Drug-Related
Mortality 
in Maine,
1997-2002
by Marcella H. Sorg
Margaret Greenwald
Since 1997, the number and rate of drug-related deaths 
in Maine have risen dramatically. Contrary to what much
of recent popular media coverage suggests, prescription
medications and not illicit drugs are involved in the
majority of these deaths, and many of these prescription
medications are used by people from all walks of life. 
In this article, Drs. Sorg and Greenwald summarize the
results of a recent statewide study to determine the charac-
teristics of those in Maine who have died from drug-related
causes over the past five years. They find that Maine’s
substance abuse problem continues to be largely an alcohol
abuse problem. Further, they find that drug deaths and, 
by implication, drug abuse problems are found in all areas
of the state, both rural and urban.  
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Drug deaths in Maine have been rising.
1 In recent
years, both the number and rate of drug-related
mortalities have increased dramatically. Since 1997,
the total annual number of drug deaths has more than
quadrupled, and accidental drug-related fatalities have
risen more than sixfold. This rapid increase has given
rise to media coverage, public concern and political
debate. All counties in Maine have been affected. As
we shall describe, the prevalence and rate of increase
in drug deaths in Maine parallels patterns found in
other rural states.
Substantial increases in mortality or mortality risk
potentially require public policy intervention. However,
in order to make good decisions about changes in
public policy that may be needed, it is necessary to
have accurate and timely data on emergent public
health and criminal justice problems such as drug-
related deaths, the subject of this article. Data from the
research reported here are being used for a range of
purposes:  to inform statewide strategic planning for
the public health response to rising opiate abuse; to
evaluate state policies on take-home dosing in
methadone clinics for opiate addiction; to underscore
the need for a statewide electronic prescription moni-
toring program; and to provide data on rural drug-
related mortality to federal agencies which regulate
opiate addiction treatment.
Attention and public concern in Maine has focused
on heroin deaths in Cumberland County, OxyContin
abuse in Washington County, and the operation of
methadone clinics around the state. Are these the only
dangerous drugs used in Maine? What are the charac-
teristics of the people who die from drug-related
causes? Do the geographic patterns publicized in the
media relate to one another? With questions such as
these in mind, Maine’s Office of Chief Medical
Examiner undertook an analysis of all drug deaths
occurring in the state from the beginning of 1997 to
the end of June 2002.2 The study’s findings provide a
comprehensive snapshot of one population of drug
users—those for whom drug use has gone tragically
awry—and therefore offer an essential perspective on
substance abuse in the state of Maine.
THE BODY OF EVIDENCE
All deaths for which druginvolvement is suspected are
referred to Maine’s Office of
Chief Medical Examiner, which
has statutory authority to inves-
tigate all suspicious, accidental,
and unintended deaths, in order
to certify their cause and
manner. This death investigation
includes a scene visit whenever
practicable. An autopsy and full
toxicology screen are routine 
in suspected drug deaths. The
medical examiner may obtain
hospital or other medical
records upon request, and may
utilize the services of consul-
tants with special expertise. The
Maine Office of Chief Medical Examiner currently has
two full-time forensic pathologists.
For each death investigated, a medical examiner 
is responsible for completion of a death certificate,
which includes:
• Demographic information about the decedent
(including age, sex, marital status, military
veteran status, birthplace, place of residence,
race, ethnicity, education, and occupation);
• Information on the processing and disposition
of the body (including whether it was viewed
by the medical examiner after death, autop-
sied or embalmed; the method [burial, crema-
tion, etc.] and place of disposition;
identification of the investigating medical
examiner; and funeral practitioner involved);
• Information on the death event (time, place,
how the injury or activity leading to death
occurred);
• The manner of death (natural, accident,
suicide, homicide or undetermined);
Since 1997,
the total annual
number of drug
deaths has more
than quadrupled,
and accidental
drug-related 
fatalities have 
risen more 
than sixfold.
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• The medical cause of death  (up to four levels
of causation may be specified, as well as
significant conditions which contributed to
the death).
Defining Drug-Related Deaths
This article reports on a study of all the cases
investigated by the Office of Chief Medical Examiner
(often referred to simply as “medical examiner cases”)
from 1997 through 2002 in which the use or abuse 
of a drug was determined to be either a cause (primary
or underlying) or a significant contributing factor.
Deaths caused by drugs are, in medical examiner
parlance, poisoning deaths. However, not all poisoning
deaths were considered drug-related fatalities. Two
categories were excluded: deaths due to the inhalation
of carbon monoxide and deaths caused by chronic
alcohol abuse in which no other drugs were implicated.
Death in which both alcohol and drugs were causal 
or contributing factors have been included.
Deaths caused directly or indirectly by drugs may
involve illicit substances (such as heroin or cocaine) or
prescription drugs. Abuse occurs when drugs are inten-
tionally taken by a legitimate prescription holder in a
manner other than prescribed, or when these drugs are
diverted (by sale, gift or theft) from prescription holders
to others. A drug-related death also may be an unin-
tended consequence of drug use. These unintended
consequences may result from drug interactions, such as
cases where multiple medical practitioners independently
prescribe for one individual, or from adverse individual
reactions to particular drugs or particular doses. When
legitimate prescription holders are involved, it is not
always easy after death to distinguish use from abuse.
Even when drugs are not the primary cause of
death, they may be an important component of the
overall causal sequence. For example, a medical exam-
iner may determine that lack of oxygen to the brain
(brain anoxia) was the immediate cause of death, but
that brain anoxia was due to methadone toxicity. In
that case, methadone would be listed as an underlying
(secondary) cause on the certificate of death.
In other cases, where death occurs as a direct
consequence of disease rather than drugs, drug use or
abuse may be a significant factor in the victim’s failure
to survive the disease. For example, in certain dosages
or under certain circumstances, a tricyclic antidepressant
may increase the potential for a cardiac arrhythmia. In
a case such as this, death may result from underlying
heart disease, but the drug exacerbates the cardiac
malfunction. So the death certificate would list cardiac
disease as the cause of death but the antidepressant
might be listed as a significant contributing factor.
Circumstances such as these provide one reason why an
autopsy is generally necessary. A microscopic examina-
tion of the major organs also may be needed to diag-
nose or exclude certain diseases.
Toxicology Testing
The investigation of drug deaths in Maine
routinely includes full toxicology testing. A comprehen-
sive toxicology screen is designed to detect a wide
range of drugs, including “analgesics, anticonvulsants,
antihistamines, antidepressants, hypnotics, narcotics,
sedatives, stimulants [and] tranquilizers” in amounts as
small as 0.001 mg/L (Central Valley Toxicology, Inc.,
www.cvtox.com).3 Though toxicology reports may
yield a wealth of information, using this information to
help determine cause and manner of death requires
considerable expertise.
The toxicology report includes a list of all drugs
in the victim’s system at the time of death, but their
presence does not necessarily mean they were a causal
or contributing factor. For example, if a cardiac patient
on methadone maintenance had taken over-the-
counter drugs for a cold, and then died of an acci-
dental digoxin overdose, the toxicology report would
include methadone, digoxin, and perhaps antihistamine
and an analgesic such as acetaminophen. However,
Even when drugs are not the primary
cause of death, they may be an important
component of the overall causal sequence.
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only digoxin would be listed as a cause of death on
the death certificate.
In some cases, use of a drug must be inferred 
from the presence of a metabolized form identified 
by the toxicology test. Some drugs metabolize quickly,
even after death. Breakdown of chemicals may be 
more extensive if there is a delay in discovering the
death. This complicates the determination of deaths
due to heroin, for example, which quickly metabolizes
to morphine in the body. Once metabolization has
occurred, prescription morphine and heroin cannot 
be differentiated. The medical examiner must consult
the victim’s medical history and police reports of the
circumstances surrounding the death in order to inter-
pret the toxicology results.
The relationship between drug levels provided 
in the toxicology report and the cause of death is not
always straightforward. Toxic drug levels sometimes
overlap with therapeutic levels, as in the case of
methadone. Further, there may be a large range of
individual variation in tolerance for a given drug; doses
needed in a person with high tolerance may be lethal
for a person with low tolerance. Drugs may interact
with one another in dangerous ways. It is possible for
an otherwise benign drug taken at a therapeutic dose to
be toxic in combination with other drugs.
The toxicology report is an essential component 
of any drug death investigation, but the interpretation
requires knowledge, experience, care, and caution. 
For this reason, our analysis gives more weight to the
medical examiner’s determination of cause of death
than to the raw data in the toxicology report.
Determining Manner of Death
Some deaths classified as natural do involve drugs.
These include deaths resulting from known effects of
accepted medical treatment, such as digitalis toxicity
from treatment of congestive heart failure. It is impor-
tant to note that when death is due to a consequence 
of chronic (long-term) substance abuse—such as with-
drawal seizures from chronic alcoholism or cardiac
inflammation (endocarditis) due to chronic intravenous
drug use—the manner is ruled natural as well (Hanzlick
1997). Unless a drug is listed by the medical examiner
as an underlying cause or a contributing factor on the
death certificate, natural deaths with positive drug 
toxicology findings are not included in our analysis.
Homicidal poisonings are very rare in Maine.
None occurred during the period covered by our study.
Not all homicides (death at the hands of another) are
legally classified as murders (intentionally taking a life).
Deaths may be classified as suicide in Maine only
if there is a “preponderance of evidence” that the
victim intended to cause his or her own death. Such
evidence might include a suicide note or history of
previous attempts. Although drug abuse in and of itself
carries with it an inherent risk of overdose and death,
engaging in risky or reckless behavior is not generally
considered sufficient evidence of suicidal intent.
Medical examiners are bound by these legal guidelines. 
Maine’s strict guidelines for what can be judged
suicide means that medical examiners classify as acci-
dents all drug deaths directly due to the unintended
or unexpected, acute (sudden or short-term) toxic
effects of a drug or poison.4 Accidental deaths thus
comprise something of a composite category; deaths
under this rubric may be the result of a range of
heterogeneous drug uses.
FIGURE 1: Number of Suicidal and Accidental Drug-related 
Deaths in Maine, 1997-2002
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In our study, as in much of the published literature
on drug deaths, we often combined accidents and
suicides for statistical purposes. When suicides and 
accidents are statistically different in some respect, 
we reported them separately.
MORTALITY RATES
The total annual number of drug deaths occurringin Maine has more than quadrupled since 1997.
During the same period accidental drug-related fatali-
ties have risen more than sixfold; recent increases are
particularly dramatic. Figure 1 shows the total number
of suicidal and accidental deaths by year. 
Drug deaths have been rising across the country.
The prevalence and rate of increase in Maine deaths
involving drugs parallels those found in other rural
states. Likewise, Maine’s drug deaths—and by inference,
drug abuse—are spread throughout the state, and thus
are not a strictly urban phenomenon (see Table 1).5
Drug deaths have occurred in every county of the
state in proportions roughly equivalent to the popula-
tion as a whole. For example, Penobscot County, with
11% of Maine’s population according to the 2000
census, was the site of 12.3% of its drug deaths. Within
counties, deaths occur in towns large and small. Though
the largest disproportion occurs in Cumberland County
(home to 21% of the state’s population but site of
33.7% of its drug-related mortalities), these statistics
FIGURE 2: Comparison of Death Rates from Intentional 
and Unintentional Poisonings in Maine,
North Carolina, and Nationally
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TABLE 1: Distribution of Maine Drug-related Deaths by County, 1997-2002
*County population percentages computed from Census 2000 data.
No. % of County’s 
Drug State-wide % of Maine
County Deaths Drug Deaths Population
Androscoggin 19 5.1% 8%
Aroostook 12 3.2% 6%
Cumberland 126 33.7% 21%
Franklin 12 3.2% 2%
Hancock 10 2.7% 4%
Kennebec 37 9.9% 9%
Knox 17 4.5% 3%
Lincoln 4 1.1% 3%
No. % of County’s 
Drug State-wide % of Maine
County Deaths Drug Deaths Population
Oxford 10 2.7% 4%
Penobscot 46 12.3% 11%
Piscataquis 3 0.8% 1%
Sagadahoc 2 0.5% 3%
Somerset 12 3.2% 4%
Waldo 5 1.4% 3%
Washington 8 2.1% 3%
York 51 13.6% 15%
State Total 374 100.0% 100%
Compared to averages for Maine’s population as a
whole, drug-death victims are more likely to be male,
slightly less likely to have been born in Maine, much
less likely to be married, and a bit less educated.
Accident victims are on average slightly younger
than those who commit suicide, more likely to be male
and less likely to be married. The mean age of all drug-
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belie the nearly exclusive media focus on Cumberland
and Washington counties. 
The overall proportionality of drug deaths relative
to total population is based on computations for the
period of study as a whole. It masks a very steep rise 
in the rate of these deaths over the course of these five
and a half years. Recent studies enable us to compare
Maine’s increase to both the United States as a whole
and to North Carolina (a more populous and racially
diverse but still largely rural state) through use of what
is termed the “Crude Death Rate” (CDR). (See Figure
2.)6 The CDR for drugs is the number of deaths per
100,000 of population due to intentional and uninten-
tional overdose. The U.S. National Vital Statistics
System has published national rates for drug-induced
deaths among non-Hispanic whites through 1999
(Minino et al. 2002). Statistics from unintentional drug
overdoses in North Carolina from 1997 through 2001
also have been compiled (Sanford 2002).
While the national drug death rate shows a small
but steady increase, Maine’s rise is precipitous. In 1997
Maine’s rate was only 40% of the national rate. Two
years later it had risen to 70% of the national rate.
Even more dramatic increases in the years since make it
likely that Maine’s drug death rate has now exceeded
the national rate. North Carolina’s increase is roughly
comparable to Maine’s. It is clear that drug deaths are
not confined to major metropolitan areas of the United
States. Risky drug use seems to be on the increase in
smaller cities, small towns, and rural areas. Who takes
these risks, and under what circumstances?
DECEDENTS
Some victims of drug-related mortality in Maine arepeople most Mainers would characterize as
marginal—without a stable place to live or a stable
work history, perhaps with histories of mental illness
or of serious substance abuse problems. Others,
however, are well-educated homeowners, employed at
responsible jobs in a variety of skilled occupations.
Aside from being (like most Mainers) overwhelmingly
Caucasian, the population of those who die of drug-
related causes is surprisingly diverse. Both men and
women of all ages (15-92) are included.
TABLE 2: Demographic Characteristics of Drug-death 
Victims, 1997-2002, Compared to Maine’s 2000 
U.S. Census Population
Maine  
Drug-death 2000  
Victims Census 
Males 62% 48%
Born in Maine 58% 67%
Married 24% 58%
Single/divorced 71% 36%
Education high school or greater 79% 85%
TABLE 3: Demographic Characteristics of Drug-death 
Victims: Suicides and Accidents, 1997-2002
All Accident Suicide
Victims Victims Victims
Age
Mean 40 38 45 
(range) (15-92) (15-92) (16-91)
Sex
Male 62% 68% 49%
Female 38% 32% 51%
Race
Caucasian 96% 95% 98%
Marital Status
Married 24% 20% 33%
Never married 39% 31% 32%
Divorced 32% 44% 29%
Education (ages 15+)
High school 50% 51% 50%
Beyond high school 29% 25% 37%
Nativity
Born in Maine 58% 60% 54%
death victims for our period of study was 40. More
than half (57%) of these decedents were aged 35-55. 
Most drug-death victims died at a residence, their
own or someone else’s. More women than men died in
a hospital. More men than women died in the open or
in a motor vehicle. These statistics may reflect stronger
social networks for women decedents. Knowing where
drug deaths occur is important for designing preven-
tion strategies as well as interventions for living victims.
Like many middle-aged Mainers, the drug death
victims had chronic medical problems, including heart,
lung and liver diseases, as well as obesity. Conditions
such as these play a role in drug-related deaths by
reducing physical capacity. For instance, liver diseases,
such as hepatitis or cirrhosis, can reduce the ability of
the liver to detoxify blood. This reduced ability plays 
a role in keeping blood drug levels dangerously high.
Chronic obstructive pulmonary disease (COPD), on the
other hand, reduces lung capacity, which can enhance
the respiratory depression produced by high levels of
opiates. Obesity can obstruct the airway, particularly 
in some body positions, thus potentially increasing 
the risk from respiratory depression caused by opiates.
Cardiovascular disease further increases risks from
respiratory depression by reducing the capacity of the
heart and lungs to process oxygen. Witnesses to the
circumstances of overdose deaths often describe the
TABLE 5: Drug-death Victims with Chronic Conditions 
Identified as a Cause or Contributing Factor 
on the Death Certificate, 1997-2002*  
as percentage of 374 total drug-death cases
* Note that more than one drug may be mentioned in a single case.
**Column percent does not add due to rounding.
TABLE 4: Location of Death, by Sex, 1997-2002
Males Females All
Hospital 51 (22.2%) 45 (31.3%) 96 (25.7%)
Residence 144 (62.6%) 89 (61.8%) 233 (62.3%)
In open 7 (3.0%) 2 (1.4%) 9 (2.4%)
Motor vehicle 2 (0.9%) 0 (0.0%) 2 (0.5%)
Nursing home 2 (0.9%) 1 (0.7%) 3 (0.8%)
Other 24 (10.5%) 7 (4.9%) 31 (8.3%)
Total 230 (100.0%) 144 (100.0%) 374 (100.0%)
DRUG-RELATED MORTALITY IN MAINE
TABLE 6: Drugs Most Frequently Mentioned on Death Certificates as a Cause or Contributing Factor, 1997-2002*
*Note that more than one drug may be mentioned in a single case.
** One polydrug case is undetermined manner and one cocaine case is a natural death.
All Drug Deaths Accidents Suicides
No. (% of No. (% of No. (% of 
374 cases) 248 cases) 123 cases)
Polydrug ** 87 (23.3%) 53 (21.4%) 34 (27.6%)
Methadone 66 (17.6%) 64 (25.8%) 2 (1.6%)
Ethanol 57 (15.2%) 38 (15.3%) 19 (15.4%)
Morphine/heroin 73 (19.5%) 69 (27.8%) 4 (3.3%)
Oxycodone 26 (7.0%) 17 (6.9%) 9 (7.3%)
Amitriptyline 24 (6.4%) 14 (5.6%) 10 (8.1%)
All Drug Deaths Accidents Suicides
No. (% of No. (% of No. (% of 
374 cases) 248 cases) 123 cases)
Cocaine 20 (5.3%) 19 (7.7%) 0 (0.0%)
Propoxyphene 16 (4.3%) 7 (2.8%) 9 (7.3%)
Fentanyl 18 (4.8%) 16 (6.5%) 2 (1.6%)
Diazepam 12 (3.2%) 9 (3.6%) 3 (2.4%)
Hydrocodone 11 (2.9%) 7 (2.8%) 4 (3.3%)
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Primary or Contributing
Secondary Cause Factor
Respiratory disease 2 (0.5%) 7 (1.9%)
Liver disease 0 (0.0%) 5 (1.3%)
Heart disease 13 (3.5%) 9 (2.4%)
Brain disease (seizure disorder) 1 (0.8%) 7 (1.9%)
Substance abuse history 0 (0.0%) 9 (2.4%)
Obesity 0 (0.0%) 9 (2.4%)
Total 16 (4.3%)** 46 (12.3%)
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victim as “sleeping” and “snoring” heavily just before
death, an unrecognized sign of respiratory distress.
Decedents may have been taking medications
prescribed legitimately for conditions such as pain.
These medications sometimes have dangerous side
effects if taken at high doses. They may interact
dangerously with one another, or with alcohol or
other drugs of abuse. Tricyclic antidepressants such as
elavil or aventyl, for example, can interfere with the
electrical function of the heart in some individuals and
at some doses. Methadone is legitimately prescribed
for treatment of pain or for narcotic dependency.
Some medications prescribed for anxiety or depres-
sion, if taken in conjunction with methadone, can
boost the blood levels—hence the toxic effects—
of both drugs (Mikolaenko et al. 2002).
Maine currently has no system of centralized
prescription registration or monitoring, although there is
a bill proposed for electronic prescription monitoring.
The certificate of death does not code for histories of
mental illness or substance abuse. To try to clarify the
relationship of prescription drugs to drug deaths, we
examined all 2001 case files for evidence of histories 
of mental illness (including depression) and drug or
alcohol abuse, as well as for information about prescrip-
tion involvement. Since this information is not collected
systematically, it must be gleaned from the medical
examiner’s report, medical records, or police reports.
The files revealed that at least 55% of all 2001
drug-death victims had a known history of mental
illness. The percentage was higher for suicide (72%)
than for accident victims (42%). About half (50%) 
of all victims had a documented history of substance
abuse. In this case, the percentage was higher for
victims of accidental death (73%) than for those who
committed suicide (16%).
Information on prescriptions could be found in 
the files of 96% of the 26 drug-related suicides that
occurred in 2001, but for only 52% of the accidental
deaths. Of the cases for which prescription information
is available, decedents in 88% of the suicides and 52%
of the accident cases had a prescription for at least one
drug identified as a cause of death. Prescription drugs
accounted for the cause of 63% of accidental deaths
during the study period and of 94% of the suicides.
DRUGS
Of the drugs specifically listed on death certificates as either cause or contributing factor, three classes
predominate: narcotics (including for example methadone,
Common Name and Drug Class 
for Frequently Occurring Drugs
Drug Common/Brand Name Drug Class
Amitriptyline ............... Elavil ........................... Antidepressant
Diazepam ..................... Valium ........................ Anti-anxiety agent
Diphenhydramine ....... Benadryl .................... Antihistamine
Ethanol ......................... Alcohol ...................... Depressant
Fentanyl ........................ Duragesic ................. Narcotic analgesic
Fluoxetine .................... Prozac ....................... Antidepressant
Hydrocodone .............. Vicodin ....................... Narcotic analgesic
Methadone .................. Methadone ............... Narcotic analgesic
Morphine/heroin ........ Morphine/heroin ..... Narcotic analgesic
Nortriptyline ............... Aventyl ...................... Antidepressant
Oxycodone ................. OxyContin ............... Narcotic analgesic
Propoxyphene ............. Darvon ...................... Narcotic analgesic
TABLE 7: Drugs Mentioned in the Death Certificate 
as Cause of Death Combined with Those Found 
in Toxicology of “Polydrug” Cases, 1997-2002*
* Categories of drugs are not mutually exclusive and only the major drug
causes are included here; thus, the column does not sum to 100%.
No. (% of 374 cases)
Methadone 86 (23.0%)
Ethanol 77 (20.6%)
Morphine/heroin 86 (23.0%)
Oxycodone 42 (11.2%)
Amitriptyline 36 (9.6%)
Cocaine 28 (7.5%)
Propoxyphene 31 (8.3%)
Fentanyl 23 (6.1%)
Fluoxetine 29 (7.8%)
Hydrocodone 22 (5.9%)
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morphine/heroin,7 oxycodone, hydrocodone, and others),
antidepressants (most frequently amitriptyline) and 
anti-anxiety agents (especially diazepam and alprazolam).
Alcohol (a depressant) and cocaine (a stimulant) are also
frequently listed.
As is seen in most other medical examiner jurisdic-
tions, victims in Maine typically have more than one
drug in their system. Drugs co-occur in many combina-
tions, making it difficult to isolate a single drug as the
cause of death. In fact, in about one-quarter (23%) of all
drug deaths, medical examiners have noted “polydrug” 
or “mixed drug” as the cause of death. In general, the
toxicology findings for these cases reflect the frequency
distribution of drugs implicated in cases where the
specific drug has been listed on the death certificate. The
drugs most frequently encountered are (in rank order)
methadone, ethanol (alcohol), and morphine/heroin.
These are the drugs most frequently implicated in Maine
drug deaths overall in 1997-2002. By contrast, the Drug
Abuse Warning Network (DAWN) lists the three drugs
most frequently implicated in overdose deaths in urban
areas in 2000 as (in order) heroin, cocaine, and alcohol
(Mortality Data 2002).
Toxicology Test Results
Because toxicology tests provide a record of all
drugs in a decedent’s system, regardless of cause of
death, they provide broader insights into patterns of
drug consumption than do the certificates of death.
The findings regarding narcotics are illustrative. Of the
267 Maine decedents who tested positive for narcotics,
81% had toxicology results that included more than
one drug. For 26% of these, two or more narcotics
were involved. The most frequently occurring narcotic-
narcotic combinations were: morphine/heroin-codeine
(10 cases), methadone-oxycodone (10 cases), and
morphine/heroin-methadone (seven cases).
Of the 267 narcotic-related deaths, 80% were
accidental deaths, and 20% were suicides. Drug distrib-
utions for these two classes of narcotic-related deaths
were markedly dissimilar. The two narcotics found most
frequently in the toxicology results for accident
victims—methadone and morphine/heroin—are not
even among the top seven drugs found in suicide
victims’ toxicology tests.
Ethanol, diazepam, and oxycodone appear on both
lists. Other drugs commonly found among suicides—
amitriptyline, propoxyphene, and fluoxetine—appear
much less frequently among accident victims.
Narcotics 
The narcotic analgesic class of drugs includes the
naturally occurring opiates (morphine, heroin, and
codeine) and synthetic opioids (including methadone,
oxycodone, hydrocodone, fentanyl, and propoxyphene).
Except for heroin, which is illicit, these drugs are
frequently prescribed for pain relief (analgesia).
Narcotics comprise the class of drugs most
commonly implicated in Maine drug deaths. One 
or more narcotic drugs are identified as a cause of
death for 198 (53%) of the 374 cases in our study.
Toxicology tests reveal that, regardless of cause of
TABLE 8: Top Five-ranked Drugs Found in Toxicology Screen and Frequency of Occurrences, 1997-2002*
*Note that some drugs share a rank.
ACCIDENTS SUICIDES ALL DRUG DEATHS
Rank Frequency (n= 248) Rank Frequency (n= 123) Rank Frequency (n= 374)
1. Methadone 181 (32.7%) 1. Ethanol 29 (23.5%) 1. Methadone 88 (23.5%)
2. Morphine/heroin 79 (31.9%) 2.Amitriptyline 19 (15.4%) 2. Morphine/ heroin 85 (22.7%)
3. Diazepam 58 (23.4%) 2. Propoxyphene 19 (15.4%) 3. Ethanol 83 (22.2%)
4. Ethanol 53 (21.4%) 3. Oxycodone 18 (14.6%) 4. Diazepam 75 (20.1%)
5. Oxycodone 45 (18.1%) 3. Diphenhydramine 18 (14.6%) 5. Oxycodone 63 (16.8%)
4. Diazepam 17 (13.8%)
5. Fluoxetine 15 (12.2%)
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death, 71% of Maine’s drug death victims had one 
or more narcotics present in their system when they
died. Narcotics most frequently involved, measured
either by cause of death on death certificates or toxi-
cology reports, were methadone, morphine/heroin, 
and oxycodone. Rates of occurrence for all three rose
sharply during the period of study. (See Figure 3.)
These three drugs have been a particular focus of
media attention and public concern. 
Methadone. Methadone is a synthetic opioid with
two distinct primary uses. Because it is long-acting,
without the same euphoric “high” as heroin, it has 
long been used in the treatment of opiate addiction.
Methadone maintenance clinics distribute the drug 
in liquid, powder or wafer form (opiate agonist
therapy). More recently, methadone has gained favor 
as a cost-effective treatment for chronic pain. Pain
clinics and private physicians prescribe it in tablet 
form. Toxicology tests cannot discriminate between
these various forms.
Methadone pharmacology is particularly complex.
Tolerances vary widely from one individual to another.
The range of blood levels for therapeutic effect overlaps
with the toxic range. People can die of fairly low, theo-
retically safe doses, often when alcohol or other drugs
are present, or if the individual has low tolerance. An
individual’s tolerance can also change with circumstance.
Tolerance is reduced for regular users who, for one
reason or another, stop receiving regular doses. When
they resume taking dosages to which they had been
accustomed, they are at greater risk for fatal overdose.
The slow onset of methadone’s effects may
prompt some users to take more methadone, with 
fatal effect. Use or abuse of other drugs in combination
with methadone may increase its toxicity or alter its
metabolic effect. Alcohol and benzodiazepines (such 
as diazepam or alprazolam) are often taken along 
with methadone. This can increase the risk of respira-
tory depression, the most common adverse effect of
all narcotics and the one most likely to prove fatal. 
Recent research also suggests an association between
methadone and cardiac arrhythmias in some individuals
(Krantz et al. 2002; Martell et al. 2003).
It should come as no surprise that methadone was
found in the toxicology results of 24% of Maine drug
deaths during the study period, with rates increasing
sharply in recent years. Methadone was the drug most
frequently found in the toxicology findings for acci-
dental overdoses, but was infrequently found in the 
toxicology reports of those who had committed suicide.
All Maine counties except Piscataquis, Sagadahoc,
and Washington had some drug deaths for which
methadone appears in the toxicology report during 
the period of study. Cumberland, York, and Penobscot
counties taken together account for 75% of these
methadone cases. However, in all counties but
Cumberland, the percentage of drug deaths with a
toxicology finding that includes methadone is roughly
proportional to the population as a whole. 
It is important to note that methadone therapy 
for opiate dependence has been used for over 30 years.
It is only recently that methadone-associated deaths
have increased. Thus, it is likely that other factors, 
such as its newer use for treating pain, may be associ-
ated with the increase. 
Because public concern has focused on the possible
involvement of methadone maintenance clinics in
methadone deaths, records of methadone deaths for
2001-2002 were analyzed to try to determine the source 
of the methadone involved. These numbers may under-
represent the number of legitimate methadone users
involved in drug-related fatalities. Medical examiners
FIGURE 3: Number of Cases in Which Key Drugs Were 
Identified by Toxicology, 1997-2002
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make every effort to contact maintenance clinics and
physicians who may have been involved. But there are
no special restrictions on prescribing methadone for pain.
In cases where medical records are incomplete, especially
where the decedent sought treatment out of state,
records may be lacking for prescriptions that do exist.
Morphine/Heroin. Heroin is an illicit drug.
Morphine sulfate may be legally prescribed as an anal-
gesic. Because heroin metabolizes rapidly to morphine,
the two drugs are indistinguishable in toxicology tests
and nearly indistinguishable in autopsy. However,
evidence of intravenous injection along with morphine
in toxicology is taken as a sign of heroin abuse. Because
heroin is an illegal substance, there is no standard dose
and purity is impossible to regulate. Therefore, it is not
surprising that morphine/heroin was the second most
frequent drug found in the toxicology reports of acci-
dental drug death victims in Maine during the period of
study. However, it was seldom found in the toxicology
results for suicides. (See Table 8.)
Drug deaths for which morphine/heroin appeared
in the toxicology report were unevenly distributed
around the state. During the period of study,
Aroostook, Lincoln, Sagadahoc and Washington coun-
ties had none. Cumberland, Franklin and Penobscot
counties had a disproportionate share. 
Oxycodone. Oxycodone is a synthetic opioid often
prescribed for pain. Since 1995 it has been marketed 
in the long-acting form OxyContin. Media attention
has focused on OxyContin abuse, particularly in
Washington County. Once metabolized, however,
OxyContin and other forms of oxycodone are indistin-
guishable. Oxycodone is listed as a cause of death on
only 7% of death certificates for drug-related cases
during 1997-2002. It is listed on 17% of toxicology
tests for drug-related deaths during this period: 15% 
of suicides and 18% of accident victims.
All Maine counties except Piscataquis had at least
one case for which oxycodone appeared in the toxi-
cology findings. In most counties, the percentage of
oxycodone deaths was roughly proportional to the
percentage of the state’s population as a whole. In four
counties the rate was higher: Aroostook, Cumberland,
Penobscot, and Washington.
CONCLUSION
Substance abuse is a critical problem facing Mainestate and local governments and the communities
they serve. Death is only the most dramatic conse-
quence of a behavior pattern associated with crime,
increased accidents, lost time at work, serious health
problems, and untold anguish for family and loved
ones. In our legitimate concerns about this serious
social problem, we often focus on its most exotic
elements—illegal drugs such as heroin or cocaine, or
legal drugs such as methadone that seem to be used
primarily by a definable “addict” population. Discussion
tends to focus on whether it is more effective to
imprison addicts, enroll them in drug treatment
programs, or even make overdose antidotes more easily
accessible. Yet the problem is much more complex.
Study of Maine’s medical examiner files on all
those involved in drug-related deaths from 1997
though June 2002 indicates that substance abuse and
legitimate drug use in Maine exist along a complex
series of continua. Use of illegal drugs by socially
marginal people is only one extreme of a large, interre-
lated set of behavior patterns. Prescription medications
are involved in the majority of Maine drug deaths.
Many of these prescription medications are used by
people from all walks of life. It is not easy to distin-
guish legitimate use from abuse, even when that use
results in death. To reduce the risk of drug-related
fatalities, policy initiatives must address this complexity
of drug use. Here we make a few points not often
made in policy debates on substance abuse issues,
simply by way of example:
Prescription medications are involved 
in the majority of Maine drug deaths.
Many of these prescription medications
are used by people from all walks of life.
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• Prescription drugs are involved in the over-
whelming majority of drug deaths in Maine.
Some of these deaths may be due to drug
diversion. Some may be due to misuse.
Others may be due to adverse interactions 
of drugs unforeseen by multiple providers
acting independently of one another.
Without some system of prescription regis-
tration or monitoring, it will be difficult to
get accurate estimates of any of these
dimensions of the problem.
• Alcohol ranked third of the substances listed
on death certificates as either cause of death
or contributing factor of drug-related deaths
in Maine, 1997-2002. Maine’s substance
abuse problem is very largely an alcohol
abuse problem.
• Because chronic medical problems were a
factor in many drug deaths, efficacious public
health measures addressing these underlying
conditions might reduce the risk of drug-
related mortality. These measures might
include weight reduction, smoking cessation,
exercise programs, and the like.
• Better public education on signs of respira-
tory distress might save lives. Unwitting
witnesses to drug deaths frequently mistake
respiratory distress for snoring and fail to
summon medical assistance.
Our study, though comprehensive in scope, was
preliminary. We hope its findings will prompt further
study of drug users in Maine. Public policy initiatives
that effectively address problems of drug use and
abuse in Maine must be based on a more detailed
understanding of the circumstances and risks of those
use patterns.  
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ENDNOTES
1.The authors would like to acknowledge, with thanks,
all those who assisted with various portions of our
data collection, analysis, or editorial work.They are 
(in alphabetical order): C.J. Bidwell, James Cameron,
Edward David, M.D., Lisa Feldman, Michael Ferenc,
M.D., James Ferland, Robert Goodrich, Lisa Hunter,
Kimberly Johnson, Charles Morris, Joanne Ogden,
David Plunkett, G. Steven Rowe, and all the staff at the
Office of Chief Medical Examiner.An earlier version of
this paper appeared as Sorg and Greenwald 2002.
2.The Maine Drug-Related Mortality Patterns project was
a collaborative effort of the Office of Chief Medical
Examiner, the Office of Attorney General, the Office
of Substance Abuse, and the Margaret Chase Smith
Center for Public Policy at the University of Maine.
Funding for the project was provided the Maine
Justice Assistance Council (Edward Byrne Memorial
Grant) and the Office of Substance Abuse. Direct
project support was provided by the Office of Chief
Medical Examiner, the Office of Attorney General,
and the University of Maine.Analysis of the data 
was performed by forensic anthropologist Marcella 
H. Sorg and Maine Chief Medical Examiner Margaret
Greenwald.
3. Central Valley Toxicology, Inc. of Clovis, California is one
of the toxicology laboratories whose services have
been employed by Maine’s Office of Chief Medical
Examiner.
4.This designation is consistent with guidelines recently
published by the National Association of Medical
Examiners (Hanzlick et al. 2002) for determining 
the manner of death when drugs are involved.
Jurisdictions outside Maine may use different criteria.
5.Although the total number of drug-related deaths 
in 2002 is provisionally known, the analysis of demo-
graphic and toxicology findings for deaths occurring
July-December 2002 has not yet been completed.
As of this time, there are four cases still pending
from 2002.
6. Maine’s data are compiled directly from the certificate
of death, medical examiner report, and toxicology
report.The North Carolina and U.S. data are based
on vital records statistics on particular “ICD-9” or
“ICD-10” categories (for intentional and unintentional
poisoning deaths) in which a Department of Health 
nosologist has coded information on the death certifi-
cate using the International Code of Diseases.There
are minor systematic differences. For example, the
North Carolina data include inhalation deaths, such 
as carbon monoxide; the Maine data do not.
7. Since heroin is toxicologically indistinguishable from
morphine when metabolozed, they are grouped
together.
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